Published in Psychopharmacology (Berl) on September 04, 2003
Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry (2010) 2.06
Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry (2008) 1.57
How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology (2008) 1.56
Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) (2005) 1.43
Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl) (2005) 1.37
Pharmacogenetics of antidepressant response. J Psychiatry Neurosci (2011) 1.28
Personalized medicine in psychiatry: problems and promises. BMC Med (2013) 1.09
Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol Psychiatry (2010) 1.07
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmgenomics Pers Med (2012) 1.04
Serotonin transporters: implications for antidepressant drug development. AAPS J (2005) 1.02
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci (2008) 0.99
Living well with stroke: design and methods for a randomized controlled trial of a psychosocial behavioral intervention for poststroke depression. J Stroke Cerebrovasc Dis (2008) 0.98
Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients. J Psychiatry Neurosci (2008) 0.95
Pharmacogenetics in drug regulation: promise, potential and pitfalls. Philos Trans R Soc Lond B Biol Sci (2005) 0.93
From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Can J Psychiatry (2014) 0.93
The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am (2010) 0.92
Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment. Psychopharmacology (Berl) (2004) 0.90
Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD? Eur Arch Psychiatry Clin Neurosci (2010) 0.89
Pharmacogenetics of antidepressant response: an update. Hum Genomics (2009) 0.89
Role of pharmacogenomics in drug discovery and development. Indian J Pharmacol (2008) 0.84
Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms. Int Clin Psychopharmacol (2010) 0.84
Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics. Eur Arch Psychiatry Clin Neurosci (2008) 0.84
Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment. Eur Neuropsychopharmacol (2012) 0.82
Pharmacogenetics of antidepressants. Front Pharmacol (2011) 0.82
Pharmacogenomic strategy for individualizing antidepressant therapy. Dialogues Clin Neurosci (2008) 0.81
Sertraline for the treatment of depression in Alzheimer disease: genetic influences. J Geriatr Psychiatry Neurol (2011) 0.78
Post-stroke depression and the aging brain. J Mol Psychiatry (2013) 0.78
Clinical implications of genetic variation in the serotonin transporter promoter region: a review. Prim Care Companion J Clin Psychiatry (2009) 0.78
Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism. Int J Impot Res (2016) 0.77
Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults. J Clin Psychopharmacol (2010) 0.77
SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Am J Geriatr Psychiatry (2013) 0.75
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences. J Geriatr Psychiatry Neurol (2015) 0.75
Emerging strategies and applications of pharmacogenomics. Hum Genomics (2004) 0.75
Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models. Pharmacogenomics (2016) 0.75
Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype. J Child Adolesc Psychopharmacol (2015) 0.75
Brain SERT Expression of Male Rats Is Reduced by Aging and Increased by Testosterone Restitution. Neurosci J (2013) 0.75
Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder. Iran J Psychiatry (2013) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry (1998) 3.07
Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A (1993) 2.80
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry (2000) 2.46
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry (2003) 2.37
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology (2000) 1.45
Serotonin transporter gene polymorphism and antidepressant response. Neuroreport (2000) 1.42
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.36
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol (2000) 1.17
Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry (2001) 1.01
Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry (2002) 0.99
New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet (2007) 13.76
RNA sequencing: advances, challenges and opportunities. Nat Rev Genet (2010) 8.96
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature (2011) 7.43
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet (2008) 6.06
Direct RNA sequencing. Nature (2009) 4.37
Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell (2010) 3.42
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature (2012) 3.40
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry (2003) 2.37
Association of the interleukin-1 gene cluster with radiographic signs of osteoarthritis of the hip. Arthritis Rheum (2004) 2.33
Chromatin profiling by directly sequencing small quantities of immunoprecipitated DNA. Nat Methods (2009) 2.26
Amplification-free digital gene expression profiling from minute cell quantities. Nat Methods (2010) 2.07
Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum (2004) 2.05
Digital transcriptome profiling from attomole-level RNA samples. Genome Res (2010) 1.83
New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanism. Nature (2010) 1.78
Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants. Genet Epidemiol (2011) 1.78
Application of pooled genotyping to scan candidate regions for association with HDL cholesterol levels. Hum Genomics (2004) 1.71
An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res (2012) 1.71
Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry (2002) 1.65
Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Hum Mol Genet (2008) 1.60
Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness. J Am Geriatr Soc (2004) 1.49
A comparison of single molecule and amplification based sequencing of cancer transcriptomes. PLoS One (2011) 1.44
Does antidepressant therapy improve cognition in elderly depressed patients? J Gerontol A Biol Sci Med Sci (2003) 1.38
Direct sequencing of Arabidopsis thaliana RNA reveals patterns of cleavage and polyadenylation. Nat Struct Mol Biol (2012) 1.34
Protocol dependence of sequencing-based gene expression measurements. PLoS One (2011) 1.19
Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes. Am Heart J (2006) 1.12
Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels. Biochim Biophys Acta (2004) 1.12
Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. Am J Cardiol (2011) 1.09
High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics. Anal Chem (2010) 1.07
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD). Hum Mutat (2008) 1.07
Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing. Hum Gene Ther (2011) 1.05
Role of a KCNH2 polymorphism (R1047 L) in dofetilide-induced Torsades de Pointes. J Mol Cell Cardiol (2004) 1.05
CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis (2005) 1.04
Single-molecule sequencing: sequence methods to enable accurate quantitation. Methods Enzymol (2010) 1.01
The properties and applications of single-molecule DNA sequencing. Genome Biol (2011) 1.00
Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry (2002) 0.99
Single-step capture and sequencing of natural DNA for detection of BRCA1 mutations. Genome Res (2011) 0.99
Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Clin Pharmacol Ther (2005) 0.98
Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis (2003) 0.96
siRNA off-target effects can be reduced at concentrations that match their individual potency. PLoS One (2011) 0.95
Single-molecule direct RNA sequencing without cDNA synthesis. Wiley Interdiscip Rev RNA (2011) 0.95
A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype. Ann Rheum Dis (2012) 0.94
Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison. J Clin Psychiatry (2004) 0.90
Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study. J Clin Psychiatry (2003) 0.89
Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline. Compr Psychiatry (2003) 0.88
Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. Am J Psychiatry (2004) 0.87
Transcriptome profiling using single-molecule direct RNA sequencing. Methods Mol Biol (2011) 0.85
On the importance of small changes in RNA expression. Methods (2013) 0.85
Medications that prolong the QT interval. JAMA (2003) 0.83
Multidimensional effects of sertraline in social anxiety disorder. Depress Anxiety (2006) 0.82
Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder. J Psychiatr Res (2002) 0.81
Cholesteryl ester transfer protein variants have differential stability but uniform inhibition by torcetrapib. J Biol Chem (2005) 0.81
Profiling of short RNAs using Helicos single-molecule sequencing. Methods Mol Biol (2012) 0.81
Multiplexed, quantitative, and targeted metabolite profiling by LC-MS/MRM. Methods Mol Biol (2014) 0.79
Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status. J Clin Psychiatry (2007) 0.79
Highly polymorphic repeat region in the CETP promoter induces unusual DNA structure. Biochim Biophys Acta (2004) 0.79
Symptoms of late-life depression: frequency and change during treatment. Am J Geriatr Psychiatry (2005) 0.78
RNA sequencing and quantitation using the Helicos Genetic Analysis System. Methods Mol Biol (2011) 0.76
Emerging strategies and applications of pharmacogenomics. Hum Genomics (2004) 0.75
Improvement of anger at one week predicts the effects of sertraline and placebo in PTSD. J Psychiatr Res (2004) 0.75
Helicos single-molecule sequencing of bacterial genomes. Methods Mol Biol (2011) 0.75